Econach Holdings
3521
Generation Pass
3195
JP-HOLDINGS
2749
Smile Holdings
7084
adish
7093
JP Stock MarketDetailed Quotes
2160 GNI Group
- 3740
- +20+0.54%
20min DelayMarket Closed Feb 26 15:30 JST
187.67BMarket Cap198.62P/E (Static)
3845High3715Low747.30KVolume3730Open3720Pre Close2.81BTurnover397052wk High1.58%Turnover Ratio50.18MShares153752wk Low18.83EPS TTM176.93BFloat Cap4070Historical High198.62P/E (Static)47.31MShs Float13Historical Low18.83EPS LYR3.50%Amplitude--Dividend TTM5.15P/B100Lot Size--Div YieldTTM
About GNI Group Company
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
Company Profile
Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees839
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Ying Luo, PhD
- Director, Representative Executive Officer, President and Chief Executive Officer
- --
- Sekitani Kazuki
- Director, Executive Officer and Chief Operating Officer
- --
- Toshiya Kitagawa
- Director, Executive Officer and Chief Financial Officer
- --
- Thomas Eastling
- Director
- --
- Ryosuke Matsui
- Director
- --
- Zhang Ping
- Independent Director
- --
- Kikuchi Kanako
- Independent Director
- --
- Hideaki Sashiwa
- Independent Director
- --